Cipla Ltd.

Cipla’s - South African subsidiary - Cipla Medpro has been awarded a contract worth 345 million rand amounting Rs 195 crore from the South African government’s national respiratory tender.

Under the contract, which will run from July 2014 to April 2017, the company will supply drugs including Beclate 100, Becalate 200 and Asthavent 200. This is the second-largest government tender awarded to Cipla in the last three years.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.